Dr Bittar educates the listeners on the core differences and similarities between ankylosing spondylitis and axial spondyloarthritis; and provides guidance on diagnosing and monitoring/ treating patients with various forms of axial diseases.
Dr Bittar educates the listeners on the core differences and similarities between ankylosing spondylitis and axial spondyloarthritis; and provides guidance on diagnosing and monitoring/ treating patients with various forms of axial diseases.
In this podcast, Dr Dubé, from U Mass Chan Medical School, discusses recent research into patient experiences in delays in diagnosis of axial spondyloarthritis.
In this podcast, Dr Dubé, from U Mass Chan Medical School, discusses recent research into patient experiences in delays in diagnosis of axial spondyloarthritis.
In part 2 of this podcast, Dr Birnbaum discusses the therapeutic options for treating nonradiographic spondyloarthritis and how to best monitor patients for progression of disease.
In part 2 of this podcast, Dr Birnbaum discusses the therapeutic options for treating nonradiographic spondyloarthritis and how to best monitor patients for progression of disease.
Patients with psoriatic arthritis who had not responded to or tolerated other therapies achieved significant improvements over 52 weeks when treated with risankizumab 150 mg.
Patients with psoriatic arthritis who had not responded to or tolerated other therapies achieved significant improvements over 52 weeks when treated with risankizumab 150 mg.
During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.
During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.